Pulmonx (LUNG) Notes Payables (2019 - 2025)

Pulmonx (LUNG) has 7 years of Notes Payables data on file, last reported at $106000.0 in Q4 2025.

• On a quarterly basis, Notes Payables fell 96.66% year-over-year to $106000.0 in Q4 2025; TTM through Dec 2025 was $106000.0, a 96.66% decrease from a year earlier, with the FY2025 full-year figure at $106000.0, down 96.66% from the prior year.
• Notes Payables for Q4 2025 stood at $106000.0, up from $105000.0 in the prior quarter.
• Over the last five years, Notes Payables for LUNG reached as high as $17.3 million in Q4 2021 and fell as low as $90000.0 in Q4 2022.
• Historically, Notes Payables has averaged $4.5 million across 5 years, with a median of $1.5 million in 2022.
• Across the five-year window, Notes Payables tumbled 99.48% in 2022 and jumped 5648.35% in 2024, its largest moves.
• Year by year, Notes Payables stood at $17.3 million in 2021, then tumbled by 99.48% to $90000.0 in 2022, then soared by 2294.44% to $2.2 million in 2023, then surged by 47.38% to $3.2 million in 2024, then sank by 96.66% to $106000.0 in 2025.
• Per Business Quant data, the three most recent Notes Payables figures were $106000.0 in Q4 2025, $105000.0 in Q3 2025, and $104000.0 in Q2 2025.